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OBJECTIVE—Genetic variants in the fat mass and obesity-
associated (FTO) gene have been linked with obesity and type 2
diabetes in European populations. We aimed to test the role of
FTO genetic variants in obesity and type 2 diabetes in the
Chinese population.
RESEARCH DESIGN AND METHODS—We genotyped 19
single-nucleotide polymorphisms (SNPs) spanning from the 3
end of the neighboring RPGRIP1L gene to the 5 ﬂanking region
of the FTO gene. We analyzed their associations with obesity
(638 case and 1,610 control subjects), type 2 diabetes (759 case
and 784 control subjects), and obesity-related traits in non-
diabetic subjects.
RESULTS—Among the 19 SNPs, the rs9939609 A allele was
strongly associated with obesity (P  7.0  10
4) and BMI (P 
0.0024) in the Chinese population. The odds ratio for obesity was
2.60 (95% CI 1.24–5.46) (P  0.011) for the AA genotype and 1.32
(1.05–1.66) (P  0.018) for the AT genotype compared with the
TT genotype. Each additional copy of the rs9936609 A allele was
associated with a BMI increase of 0.37 kg/m
2. The rs9939609 A
allele was substantially less common in the Chinese population
than in the European population (12.6 vs. 45%). We did not ﬁnd
signiﬁcant associations of the 19 SNPs with type 2 diabetes or
other obesity-related traits.
CONCLUSIONS—Genetic variation in the FTO gene is strongly
associated with obesity and BMI in the Chinese population. The
risk variant is less common in the Chinese population, but its
effect size on BMI is comparable with that in the European
population. Diabetes 57:2245–2252, 2008
O
besity is strongly inﬂuenced by genetic factors,
with an estimated heritability of 60% BMI
(1,2). Genetic susceptibility to the common
form of obesity appears to be polygenic. Al-
though theoretical analyses emphasized the power of
genetic association study in common polygenic diseases,
the search for genes conferring the risk of obesity has thus
far not been very successful. A few reported associations
with genes such as GAD2, ENPP1, and INSIG2 also
yielded inconsistent results in replication efforts (3–5).
Recently, several independent studies using different
approaches reported strong associations of genetic vari-
ants in the fat mass and obesity-associated (FTO) gene
with obesity in populations of European origin (6,7).
Zeggini et al. (8) initially found the association of FTO
genetic variants with type 2 diabetes in a genome-wide
association study for type 2 diabetes. However, the asso-
ciation was abolished by adjustment for BMI, indicating
that the association with type 2 diabetes was mediated
through an effect of obesity (8). They replicated the
associations (rs9939609) with obesity in a total of 38,759
individuals (6). Dina et al. (7) concurrently reported strong
associations of single-nucleotide polymorphisms (SNPs)
(rs1421085 and rs17817449) of the FTO gene with child-
hood and severe adult obesity. Two other genome-wide
association studies (9,10) also independently reported the
associations of nearby FTO genetic variants (rs9930506,
rs8050136, rs7193144, rs1121980, and rs9939973) with obe-
sity and obesity-related traits in European and Hispanic
populations. All these SNPs fall in a region of strong
linkage disequilibrium (LD) in intron 1 of the FTO gene
(11). The effect of FTO genetic variants on common
obesity is also substantial in the European population.
Adults who are homozygous for the risk-conferring
rs9939609 A allele weighed 3 kg more and had a 1.67-fold
increased odds ratio of obesity when compared with those
without a risk allele (6). The calculated population-attrib-
utable risk is 22% for common obesity in populations of
European origin (6).
Reproducibility is essential for reported genetic associ-
ations, especially among populations of different ethnic
backgrounds. However, studies in an Oceanic population
(12), African Americans (10), Han Chinese (13), and Jap-
anese (14) failed to detect associations between previ-
ously reported SNPs and obesity or obesity-related traits.
Although the limited sample size and power of these
studies is the most likely reason for the lack of association,
there is emerging evidence showing that other FTO SNPs
not in LD with rs9939609 may be the causative variant in
non-European populations (15). In this study, we aimed to
investigate the association of FTO genetic variants with
obesity and type 2 diabetes in the Chinese population.
Instead of testing only a few variants, we used a gene-
based approach (16) by selecting potentially functional
and common SNPs from the 3 end of the neighboring
RPGRIP1L gene to the 5 ﬂanking region of the FTO gene.
Their associations with obesity-related quantitative meta-
bolic traits were also analyzed.
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We recruited 594 young obese case subjects from the bariatric surgery clinics
of En Chu Kong General Hospital in Taiwan. Obesity was deﬁned as BMI 30
kg/m
2. A total of 759 type 2 diabetic case subjects were recruited from the
metabolic clinic of the National Taiwan University Hospital. Type 2 diabetes
was diagnosed based on the criteria of the American Diabetes Association
(17). We excluded diabetic patients with ages of onset 35 years.
We recruited 910 healthy nonobese control subjects from the health
checkup service of the National Taiwan University Hospital and a community-
based health screening program in Taiwan. Nonobesity was deﬁned as BMI
30 kg/m
2. Among them, 784 were conﬁrmed to be normal glucose tolerant
after a 75-g oral glucose tolerance test.
The case-control association analysis for type 2 diabetes included the 759
type 2 diabetic case and 784 control subjects with normal fasting glucose and
glucose tolerance. They were not matched for age, sex, or BMI. The case-
control association analysis for obesity included 594 young obese case and
910 healthy nonobese control subjects. We further incorporated type 2
diabetic case subjects with available BMI data (n  744) into the analysis. In
total, 638 obese case subjects (594 young obese case and 44 obese type 2
diabetic case subjects) and 1,610 nonobese control subjects (910 healthy
nonobese control and 700 nonobese type 2 diabetic case subjects) were used
in the case-control association analysis for obesity. Association analysis for
BMI was performed in all subjects with available BMI data. The association
analyses for other obesity-related metabolic traits were performed in all
nondiabetic subjects with available metabolic traits. Written informed consent
was obtained from every participating subject, and the study was approved by
the institutional review board of the National Taiwan University Hospital.
Clinical measurements. BMI was calculated as weight in kilograms divided
by the square of height in meters. Plasma glucose was determined using a
glucose oxidase autoanalyzer (Daikin Antsense II; Daikin, Osaka, Japan), and
plasma insulin was measured using a radioimmunoassay (Abbott AxSYM;
Abbott Diagnostics, Abbott Park, IL). Fasting total cholesterol, triglycerides,
HDL and LDL cholesterol, and uric acid levels were measured using a
dry-chemistry autoanalyzer (Fuji FDC-3000; Fuji Film, Tokyo, Japan). Serum
high-sensitive C-reactive protein concentration was measured with a turbidi-
metric immunoassay utilizing an autoanalyzer (Toshiba TBA-120FR; Toshiba
Medical Systems, Tokyo, Japan). The homeostasis model assessment of
insulin resistance was calculated from fasting insulin concentration (mU/l) 
plasma glucose (mmol/l)/22.5 (18). The homeostasis model assessment of
-cell function was calculated as 20  fasting insulin (mU/l)/(fasting plasma
glucose [mmol/l]  3.5) (18).
Selection of SNPs and genotyping. We selected potentially functional and
common SNPs from the 3 end of the neighboring RPGRIP1L gene to the 5
ﬂanking region of the FTO gene by using FASTSNP (Functional Analysis and
Selection Tool for Single Nucleotide Polymorphism) software (19). The
FASTSNP software is a web server that allows users to efﬁciently identify and
prioritize SNPs according to their putative functional effects. The prioritiza-
tion strategy is based on the priority proposed by Tabor et al. (20). All SNPs
in the FTO gene with possible function effects are predicted as “intronic
enhancers,” which are intronic SNPs with a potential transcriptional factor
binding site. We selected only SNPs with known minor allele frequencies
15% in the Chinese population. Twenty SNPs were selected. Among them,
SNP rs1421092 is located in intron 1 of the RPGRIP1L gene. Other SNPs are
located in intron 1 (rs11861870), intron 4 (rs2388405), intron 7 (rs2287142),
intron 8 (rs16952730, rs16952777, rs4784338, rs1107355, rs12443572,
rs13331869, rs12600060, rs16952987, rs918031, and rs1008400), and the 5
ﬂanking region (rs1588413, rs11076022, rs11076023, rs12597712, rs2072518,
and rs2075205) of the FTO gene. Because all FTO variants (rs7193144,
rs8050136, rs9939609, rs9930506, rs1121980, and rs17817449) with known
associations with obesity and type 2 diabetes in European populations (5–10)
are 15% in the Chinese population and are in strong LD (mean r
2  0.87 and
mean D1) according to the HapMap Chinese in Beijing (CHB) databank
(11), we additionally selected rs9939609 as a tag SNP capturing these SNPs.
Genotyping was performed in a total of 21 SNPs using the GenomeLab
SNPstream genotyping platform (Beckman Coulter, Fullerton, CA) and its
accompanying SNPstream software suite. On average, 97.96% of attempted
genotypes were successful, except for rs2388405 and rs2287142, in which
genotyping failed in all samples. The concordance rate of genotyping dupli-
cation was 99.62%, based on 40 duplicate samples for each SNP. These 19
SNPs captured 96 of 407 alleles (23%), with frequencies 5% at an r
2 of 0.8
across a region of 419 kb containing the FTO gene from the HapMap CHB
database (build 35 release) (11).
Statistical analyses. Genotype data of both case and control groups were
used to estimate intermarker LD by pairwise D and r
2. We used the solid
spine of the LD method implemented in the Haploview software (available at
http://www.broad.mit.edu/mpg/haploview/) to deﬁne an LD block with an
extended spine of D0.8 (21). To compare the LD structures of a 419-kb
region containing the FTO gene between Chinese and European populations,
we used the genotype data from the CHB (Han Chinese) and CEU (Centre
d’Etude du Polymorphisme Humain, Utah residents of northern and western
European ancestry) databases in the HapMap (build 35). The LD structures
were visualized using the Haploview software.
A Hardy-Weinberg equilibrium test was performed for each SNP for the
control group before marker-trait association analysis. The associations of
each SNP with obesity and type 2 diabetes were estimated using logistic
regression under a log-additive model implemented in the PLINK software
(available at http://pngu.mgh.harvard.edu/purcell/plink/) (22). We tested the
model ﬁt for disease association by comparing additive, dominant, and
recessive models using logistic regression. Nominal two-sided P values were
reported and were corrected for multiple testing by permutation for 10,000
times.
For quantitative trait analyses, all metabolic traits including BMI were
logarithmically transformed and standardized to the Z score units. The
associations of each SNP with metabolic traits and the per-allele effect size on
metabolic traits were estimated using linear regression in an additive genetic
model in PLINK. We tested the model ﬁt for metabolic traits association by
comparing additive, dominant, and recessive models using linear regression.
Nominal two-sided P values were reported and were corrected for multiple
testing by permutation for 10,000 times.
In the case-control association study for obesity and association analysis
for quantitative metabolic traits, we combined samples from different study
populations. We used the Cochran’s Q test for heterogeneity and the I
2
statistics to estimate heterogeneity between study populations. Meta-analysis
of obesity association for the combined samples was performed using the
ﬁxed-effects Cochran-Mantel-Haenszel method implemented in PLINK. The
combined odds ratio and signiﬁcance level was estimated using the study
population as strata. For quantitative metabolic trait association analyses in
the combined samples, we used inverse variance methods implemented in the
Comprehensive Meta-Analysis Software version 2 (Biostat, Englewood, NJ) to
estimate the combined effect size on BMI and signiﬁcance level.
To provide an approximate estimate of the per-allele effect size in BMI
units (kg/m
2), we used the methods adopted by Frayling et al. (6). The Z score
unit differences were translated into BMI units using the SD of BMI in the
general Chinese population (3.01 kg/m
2 in healthy control subjects of this
study).
The population-attributable risk fraction was estimated with data from the
control group, calculated as follows: 1  (1/[p
2 ORhomo 	 2p {1  p} ORhetero	
{1  p}
2]), where p is the risk-allele frequency, ORhomo is the odds ratio for
homozygotes, and ORhetero is the odds ratio for heterozygotes. Power calcu-
lations were performed using a Genetic Power Calculator (available at
http://pngu.mgh.harvard.edu/purcell/gpc/) (23).
RESULTS
Basic demographic data, SNP information, and struc-
ture of LD. The baseline characteristics of participants
are shown in Table 1. The basic information of the 19
genotyped SNPs is summarized in online appendix Table 1
(available at http://dx.doi.org/10.2337/db08-0377). Graphi-
cal representation of SNPs in relation to the exon-intron
structure and the LD pattern between markers are de-
picted in Fig. 1. We compared the structures of LD across
a 419-kb region containing the FTO gene using genotype
data from the CHB and CEU HapMap samples. The LD
structures across this region shared high similarity be-
tween the two populations (online appendix Fig. 1).
Association analysis of genetic variants of the FTO
gene with obesity and BMI. The rs9939609 A allele was
identiﬁed as the risk variant for obesity in populations of
European ancestry (6). Among the 19 SNPs in this study,
the rs9939609 A allele was strongly associated with obesity
(P  7.0  10
4) (Table 2) (Fig. 2). The per–A allele
increase of odds ratio for obesity was 1.43 (95% CI
1.16–1.75) (Table 2 and online appendix Fig. 2). The
association remained signiﬁcant after correction for mul-
tiple testing. The genotypic odds ratio for obesity was 2.60
(1.24–5.46) (P  0.011) for the AA genotype and 1.32
(1.05–1.66) (P  0.018) for the AT genotype. The genetic
model was best ﬁt with an additive model (P  7.0  10
4,
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model, respectively). When different criteria for obesity
were applied (24), the associations were also signiﬁcant
(allelic P  7.6 10
4 for obesity deﬁned as BMI 28 kg/m
2
and 0.0081 for BMI 27 kg/m
2). The frequency of the
rs9939609 A allele (12.6%) was substantially lower in our
study than that of European populations (45%) (6),
corresponding to a lower population-attributable risk frac-
tion of 8.7% in the Chinese population.
The rs9939609 A allele was also associated with increased
BMI (P  0.0024) (Fig. 2) and weight (P  0.0065). In our
study cohort, carriers with AA genotype ([means 
 SD] BMI
31.52 
 8.76 kg/m
2) and AT genotype (28.75 
 7.89 kg/m
2)
were heavier than those with TT genotypes (28.08 
 8.45
kg/m
2)( P  0.0088 and 0.048, respectively) (Fig. 3). The
genetic model was best ﬁt with an additive genetic model
(P  0.0024, 0.0091, and 0.073 for additive, recessive, and
dominant models, respectively). Each additional copy of the
rs9939609 A allele was associated with a BMI increase of a
mean 0.124 Z score units, equivalent to 0.37 kg/m
2 or 1.07
kg body wt for a person 1.7 m tall (online appendix Fig. 2).
The extent of variance in BMI explained by rs99399609 was
0.5% in the Chinese population.
There was no heterogeneity in the per–A allele increase
of odds ratio for obesity and effect size on BMI among
different study populations (online appendix Fig. 2). We
did not detect any signiﬁcant interaction between
rs9939609 genotype and age or sex on the risk of obesity or
BMI (data not shown).
Association analysis of genetic variants of the FTO
gene with type 2 diabetes. We did not observe signiﬁ-
cant association between rs9939609 and type 2 diabetes.
Two SNPs (rs16952777 and rs1107355) in LD block 1 were
nominally associated with type 2 diabetes (Table 3). SNPs
FIG. 1. Graphical representation of SNPs in relation to the exon-intron structure (upper part) and Haploview LD graph of the FTO gene (lower
part). The exon regions are shown with ﬁlled rectangles and numbered in order. Pairwise LD coefﬁcients D  100 was shown in each cell (D
values of 1.0 were not shown). Alternative D/logarithm of odds color scheme of Haploview was applied for LD color display (high logarithm of
odds score and high D in black; high logarithm of odds score and low D in white; low logarithm of odds score and high D in shades of gray; low
logarithm of odds score and low D in white).
TABLE 1
Basic characteristics of the study subjects
n Male-to-female ratio Age (years) BMI (kg/m
2)
Obesity case-control study
Case subjects 638 219:419 37.00 
 0.56 38.86 
 8.19
Control subjects 1,610 822:788 61.08 
 0.33 24.04 
 2.89
Type 2 diabetes case-control study
Case subjects 759 381:378 60.03 
 11.85 24.66 
 3.40
Control subjects 784 438:346 63.37 
 14.0 23.63 
 3.08
Data are means 
 SD, unless otherwise indicated.
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2248 DIABETES, VOL. 57, AUGUST 2008in the same block were also nominally associated with
fasting glucose concentrations in nondiabetic subjects
(online appendix Table 2). However, none of these asso-
ciations remained signiﬁcant after adjustment for multiple
testing.
Association of FTO genetic variants with obesity-
related metabolic traits. Results from the association
analysis with other obesity-related metabolic traits are
shown in online appendix Table 2. We did not observe
signiﬁcant association between rs9939609 and obesity-
related metabolic traits, including fasting glucose, insulin,
cholesterols, triglycerides, uric acid, C-reactive protein,
and blood pressure. We found nine hypotheses with Pnominal
 0.05, but none of them remained signiﬁcant after per-
mutation testing. A borderline-signiﬁcant association re-
sult was obtained between homeostasis model assessment
of -cell function and rs1421092 after permutation testing
(Ppermuted  0.054).
DISCUSSION
Genetic polymorphisms of the FTO gene are the only
genetic variants that have been reproducibly associated
with obesity in populations of European ancestry
(6,7,9,10). However, these associations were controversial
in Asian populations. Li et al. (13) found no association of
FTO variants with obesity and BMI in the Chinese popu-
lation. Horikoshi et al. (14) also found no association of
FTO variants with BMI in the Japanese population. In
contrast, another group reported that rs9939609 was asso-
ciated with BMI in the Japanese population (25). A recent
study (26) also found strong associations of rs9939609 and
other SNPs located in the intron 1 LD block with severe
obesity in the Japanese population. In this study, we
conﬁrmed the strong association of FTO genetic variants
with obesity and BMI in a Han Chinese population. This is
one of the ﬁrst studies that successfully replicated the
association of FTO genetic polymorphisms with obesity in
the Chinese population. Furthermore, we found that the
effect size of the rs9939609 A allele on obesity risk and BMI
are comparable with that in European populations (6,7).
However, the risk allele was much less common in the
Chinese population than in European populations (12.6 vs.
45%), leading to a lower population-attributable risk frac-
tion (8.7 vs. 22%). Only 1.7% of the Chinese population
were homozygotes of the A allele, in contrast to 16% in
European populations. The variance of BMI explained by
rs9939609 was also lower (0.5%) when compared with
European populations (1%). Previous analyses suggested
that purifying selection (negative selection) has operated
on the FTO gene since the divergence of chimpanzee and
human (12). It will be of interest to reconstruct the
phylogenic relationship between FTO genetic variants and
to explore possible adaptive evolution to environmental
changes.
Li et al. (13) recently reported no association of FTO
genetic polymorphism in the intron 1 block (rs9939609,
rs8050136, and rs9930506) with obesity in the Chinese
population. The reason for the discrepancy is not known.
The sample size and design of the study by Li et al. was
comparable with our study and was sufﬁciently powered.
However, our study recruited mainly young obese case
subjects. This approach may increase the genetic load and
decrease the interference of environmental effects. It is
also possible that unrecognized difference in population
structure existed between two study populations. Li et al.
also proposed that other FTO variants outside the intron 1
block might be associated with obesity. Therefore, instead
of testing only few variants, we adopted a gene-based
approach by selecting common and potential functional
SNPs across the FTO and nearby RPGRIP1L gene. Al-
though the coverage of FTO genetic variation was far from
sufﬁcient using this approach, the highest association
signal appeared in the intron 1 of the FTO gene. Consistent
with our ﬁndings, Hotta et al. (26) also found the highest
association signals with severe obesity in the intron 1
block of the FTO gene. These data indicate that the
underlying causative variant is located in the intron 1
block or is in strong LD with SNPs in the intron 1 block in
the Chinese or Japanese populations, similar to the ﬁnd-
ings in European populations (6,7,9,10).
We did not detect an association of rs9939609 with type
2 diabetes in our study. Only nominal associations of two
SNPs located in a nearby LD block were found with type 2
diabetes and fasting glucose. However, assuming an allele
frequency of 12.5%, an allelic relative risk of 1.17 (8,27,28),
and diabetes prevalence of 8% in the Chinese population in
Taiwan, enrollment of 2,300 case subjects would be
necessary for the case-control study to have 80% power
(23). A sample size of at least threefold of the present
FIG. 2. Associations of SNPs near the FTO and RPGRIP1L gene regions
of chromosome 16 with obesity and BMI in the Chinese population.
FIG. 3. BMI according to genotype at rs9939609. Data were expressed
as means SE (error bars).
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FTO AND OBESITY IN CHINESE
2250 DIABETES, VOL. 57, AUGUST 2008study would be needed to detect the effect. Therefore, our
study is underpowered to detect such association. Fur-
thermore, the type 2 diabetic case subjects in our study
cohort was comprised of mostly nonobese subjects
(mean BMI 24.66 kg/m
2). This is in contrast to the type 2
diabetic case subjects in the Welcome Trust Case Control
Consortium and U.K. Type 2 Diabetes Genetic Consortium
(mean BMI 30.95 kg/m
2) (8,27,28). The lower BMI of type 2
diabetic case subjects in our study would weaken the genetic
contribution of FTO to type 2 diabetes. In accord with our
study, two studies in Japanese and Chinese populations also
yielded insigniﬁcant associations of rs9939609 with type 2
diabetes (13,25). Horikoshi et al. (14) reported a nominal
association of rs8050316 with type 2 diabetes, but no associ-
ation was found with rs9939609 in Japanese. The mean BMI
of type 2 diabetic case subjects in these studies was similar to
our study. Given the lower risk allele frequency and the
relatively leaner body build of type 2 diabetic patients in the
Chinese and Japanese population, larger sample size is
needed to detect the association with type 2 diabetes, and the
genetic contribution of FTO to type 2 diabetes may be of less
importance in these populations.
We did not observe signiﬁcant associations of obesity-
related metabolic traits with SNPs near the FTO gene.
Three studies (13,14,26) in Chinese and Japanese popula-
tions also failed to detect signiﬁcant associations with
obesity or type 2 diabetes–related metabolic traits includ-
ing fasting glucose, insulin, lipids, and blood pressure.
However, a meta-analysis in 17,037 Caucasians found
signiﬁcant associations of the FTO genotype with fasting
glucose, insulin, triglycerides, and HDL cholesterol (29).
Again, the most probable reason for lack of association in
the Chinese and Japanese population is the lack of ade-
quate power. A similar meta-analysis combining all studies
in these populations may be needed to improve the power.
In summary, we conﬁrmed the association of FTO
genetic polymorphisms with obesity and BMI in the Chi-
nese population. The risk allele is much less common in
the Chinese population, but its effect size on obesity risk
and BMI were comparable with those in European popu-
lations. We did not observe a signiﬁcant association of
FTO genetic polymorphism with type 2 diabetes, probably
due to inadequate power. Given the lower risk allele
frequency and the leaner body build of type 2 diabetic
patients in the Chinese population, the genetic contribu-
tion of FTO gene to type 2 diabetes in the Chinese
population may be less than that in European populations.
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